Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
IGF-1 LR3
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Growth Hormone › IGF-1 LR3
← Back to catalog Growth HormoneComing Soon

IGF-1 LR3 (1 mg)

IGFAnabolicLong R3
$280 USD1 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

IGF-1 analog with Long R3 mutation — extended half-life and low affinity to binding proteins. The direct effector of the GH axis.

  • Mechanism: IGF-1 analog with lower binding-protein affinity (~20-30 h half-life); IGF-1 receptor known.
  • Evidence: Mostly preclinical and anecdotal in performance.
  • In context: Hypoglycemia; pro-growth signal (tumor caution).

Not in stock yet. Message us on WhatsApp and we'll let you know as soon as it arrives.

Research range · SC
20–100 mcg per application · once daily
🔴 Research convention · research convention

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundIGF-1 LR3
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC400H625N111O115S9
Molecular weight9117.5 g/mol
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

IGF-1 LR3: research profile

IGF-1 LR3 (Long R3 IGF-1) is a recombinant analog of human insulin-like growth factor 1 with two changes: an arginine in place of the glutamate at position 3 (“R3”) and a 13-amino-acid extension at the N-terminus (“Long”), taking the molecule from 70 to 83 amino acids and about 9.1 kDa. It was developed in Australia (GroPep, University of Adelaide) as a cell-culture reagent, which remains its main use: it replaces insulin and IGF-1 in mammalian cell-culture media.

The purpose of the modifications is to reduce affinity for the IGF-binding proteins (IGFBPs), which sequester more than 99% of natural IGF-1 in plasma. By escaping them, LR3 stays free, binds the IGF-1 receptor with similar affinity and proves two to three times more potent in vitro; its circulating half-life is estimated at 20–30 hours, against minutes for free IGF-1. The receptor activates the PI3K–Akt and MAPK pathways, with effects on glucose uptake, protein synthesis and cell proliferation.

There are no clinical trials of IGF-1 LR3 in humans: data come from cell culture, animal models and anecdotal performance use. Native recombinant IGF-1 (mecasermin) is an approved medicine for severe primary IGF-1 deficiency, and its label documents hypoglycemia, lymphoid tissue hypertrophy and the oncologic caution proper to a mitogenic factor; those considerations extrapolate to LR3 with greater uncertainty. It is on the World Anti-Doping Agency list. Renova distributes it for research only.

IGF-1 LR3 technical data

ClassLong-acting recombinant analog of human IGF-1
StructureIGF-1 with Glu3→Arg and a 13-aa N-terminal extension · 83 amino acids · ≈ 9.1 kDa
CAS946870-92-4
OriginGroPep / University of Adelaide (Australia); cell-culture reagent
Key propertyGreatly reduced IGFBP affinity → larger free fraction; in-vitro potency ×2–3
Estimated half-life20–30 hours (versus minutes for free IGF-1)
Receptor and pathwaysIGF-1R → PI3K–Akt, MAPK
Regulatory statusNot approved; WADA list (S2) · requires strict cold chain (protein)

Questions about IGF-1 LR3

What do “Long” and “R3” mean in IGF-1 LR3?

“R3” indicates that the glutamate at position 3 was swapped for an arginine, and “Long” that a 13-amino-acid extension was added to the start of the protein. Together they drastically reduce binding to the IGF carrier proteins, so the molecule circulates free and active for longer.

Is IGF-1 LR3 the same as growth hormone?

No. GH is the pituitary hormone that instructs the liver to produce IGF-1; IGF-1 is the final effector of that axis. LR3 acts directly on the IGF-1 receptor, bypassing GH and the regulation the axis imposes. That is why it does not appear alongside secretagogues in the literature.

What is IGF-1 LR3 actually used for?

Its established use is in biotechnology: cell-culture media, where it replaces insulin or IGF-1 to sustain proliferation of mammalian cells. There are no human clinical trials; use in athletic performance is anecdotal and prohibited by the World Anti-Doping Agency.

What safety considerations does the IGF-1 literature describe?

For the approved recombinant IGF-1 (mecasermin), hypoglycemia, growth of lymphoid tissue and the oncologic caution that accompanies any mitogenic factor are documented. For LR3, with a larger free fraction and longer half-life, those considerations extrapolate with greater uncertainty since no human data exist.

Related reading: IGF-1 LR3: Long-Acting Analog · CJC-1295 + Ipamorelin: The Most-Studied GH Stack

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty